ITM2B and Alzheimer disease: Intravenous administration of rh Bri2 BRICHOS R221E for 10–12 weeks in App knockin mouse models results in apparent accumulation of the protein in the brain, including in neurons (Figure 2), and the treatment regimen is well tolerated (Figure 3) and improves multiple AD features in the mice (Figure 8).